BALTIMORE (Stockpickr) -- Health care stocks have been good for your portfolio's health in recent months -- and they're likely to stay that way as we dig deeper into 2014.
>>5 Stocks Set to Soar on Bullish Earnings
From a technical standpoint, the health care sector has been one of the best-performing collections of stocks since before the start of the summer, even besting the S&P 500's impressive rally in 2013. So with a somewhat lackluster New Year catching investors' attention in January, it makes sense to keep buying what works.
That doesn't mean it's smart to buy any health care names right now, but the stocks showing technical strength in this market should continue to stomp the big indices. Today, we'll take a closer technical look at five of them.
For the unfamiliar, technical analysis is a way for investors to quantify qualitative factors, such as investor psychology, based on a stock's price action and trends. Once the domain of cloistered trading teams on Wall Street, technicals can help top traders make consistently profitable trades and can aid fundamental investors in better planning their stock execution.
Top India Companies To Own In Right Now: Ishares Gold Trust (IAU)
ishares Gold Trust (the Trust), incorporated on January 21, 2005, is to own gold transferred to the Trust in exchange for shares issued by the Trust (Shares). Each Share represents a fractional undivided beneficial interest in the net assets of the Trust. The assets of the Trust consist of gold held by the Trust�� custodian on behalf of the Trust. The sponsor of the Trust is BlackRock Asset Management International Inc. (the Sponsor). The trustee of the Trust is The Bank of New York Mellon (the Trustee) and the custodian of the Trust is JPMorgan Chase Bank, N.A., London branch (the Custodian).
The activities of the Trust are limited to issuing Baskets of Shares in exchange for the gold deposited with the Custodian as consideration; selling gold as necessary to cover the Sponsor�� fee, Trust expenses not assumed by the Sponsor and other liabilities, and delivering gold in exchange for Baskets of Shares surrendered for redemption. It does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of gold.
Advisors' Opinion:- [By WilliamBriat]
For those investors who agree with this position that gold bullion should be a part of their portfolio, you may want to look at exchange-traded funds (ETFs) like the iShares Gold Trust (NYSE: IAU). This ETF provides investors with exposure to gold bullion, and it’s a cheaper alternative to the SPDR Gold Shares (NYSE: GLD) ETF.
- [By Sean Williams]
The first method is by purchasing an ETF that closely tracks the underlying price of gold. The iShares Gold Trust (NYSEMKT: IAU ) and SPDR Gold Shares (NYSEMKT: GLD ) are two easy ways of buying into an ETF that holds physical gold without having to go through a physical gold dealer and taking delivery of the product. Also, both ETFs are extremely liquid, which means that you can access your money through your favorite brokerage by buying or selling anytime you need. The downside, of course, is that physical gold offers no dividend yield, so it's all about the price appreciation potential here.
- [By Quoth the Raven]
The other common way to invest is through ETFs such as iShares Gold Trust (IAU), which basically track the price of the commodity by physically purchasing bullion. The ETFs asset price reflect the price as which it trades for. If the underlying asset is silver, the ETF trades proportional to what the silver's worth.
- [By Peter Pham]
Although the Fed doubled its bond buying last September, the top gold exchange-traded funds, or ETFs, including SPDR Gold Shares (NYSEMKT: GLD ) , iShares Gold Trust (NYSEMKT: IAU ) , and ETFS Physical Swiss Gold Shares (NYSEMKT: SGOL ) , have dropped around 25% each over the last 12 months, which speaks to gold's extreme vulnerability to QE tapering. Even the mere mention of tapering seems to send gold into a tailspin, as seen with SPDR Gold Shares, which has plunged 24% year to date and also suffered massive losses with its physical holdings. Market Vectors Gold Miners ETF (NYSEMKT: GDX ) has suffered a massive drop of 48% so far in 2013, making it one of the worst-performing ETFs this year.
Top Performing Companies To Own For 2014: Alexza Pharmaceuticals Inc.(ALXA)
Alexza Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions worldwide. Its product candidates are based on a proprietary technology, the Staccato system, which vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. The company?s lead product candidate includes ADASUVE (Staccato loxapine) for the acute treatment of agitation in adults with schizophrenia or bipolar disorder. Its other product candidates under development comprise AZ-007 (Staccato zaleplon), which has completed Phase I clinical trials for the treatment of insomnia; and Staccato nicotine that is in pre-Phase 1 clinical trials to help smokers quit by addressing both the chemical and behavioral components of nicotine addiction by delivering nicotine replacement through inhalation. The company was f ormerly known as Alexza Molecular Delivery Corporation and changed its name to Alexza Pharmaceuticals, Inc. in July 2005. Alexza Pharmaceuticals, Inc. was founded in 2000 and is headquartered in Mountain View, California.
Advisors' Opinion:- [By Roberto Pedone]
Another under-$10 stock that's starting to move within range of triggering a big breakout trade is Alexza Pharmaceuticals (ALXA), which is focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. This stock hasn't done much so far in 2013, with shares up by just 5.6%.
If you take a look at the chart for Alexza Pharmaceuticals, you'll notice that this stock has been uptrending strong for the last month, with shares moving higher from its low of $4.23 to its recent high of $5.52 a share. Following that uptrend, shares of ALXA have now started to trend sideways and consolidate between $4.95 on the downside and $5.52 on the upside. Shares of ALXA are now starting to spike within range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern.
Market players should now look for long-biased trades in ALXA if it manages to break out above some near-term overhead resistance levels at $5.40 to $5.52 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 256,570 shares. If that breakout triggers soon, then ALXA will set up to re-test or possibly take out its 52-week high at $6.65 a share, or its next major overhead resistance level at $7.60 a share.
Traders can look to buy ALXA off weakness to anticipate that breakout and simply use a stop that sits right below its 50-day moving average at $4.77 a share, or near its 200-day moving average at $4.63 a share. One can also buy ALXA off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By Monica Wolfe]
Alexza Pharmaceuticals (ALXA)
As Alexza Pharmaceuticals��price has continued to stay at a 10-year low price, President and CEO Thomas King decided to increase his holdings in the company.
- [By Roberto Pedone]
Alexza Pharmaceuticals (ALXA) is a pharmaceutical company focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. This stock closed up 1.9% to $4.63 in Tuesday's trading session.
Tuesday's Range: $4.51-$4.73
52-Week Range: $2.91-$6.65
Tuesday's Volume: 509,000
Three-Month Average Volume: 421,914From a technical perspective, ALXA trended modestly higher here right off its 50-day moving average at $4.48 with above-average volume. This move is quickly moving shares of ALXA within range of triggering a major breakout trade. That trade will hit if ALXA manages to take out some near-term overhead resistance levels at $4.80 to $4.86 and then once it clears more resistance at $5.20 with high volume.
Traders should now look for long-biased trades in ALXA as long as it's trending above its 50-day at $4.48 or above more support at $4.20 and then once it sustains a move or close above those breakout levels with volume that hits near or above 421,914 shares. If that breakout triggers soon, then ALXA will set up to re-test or possibly take out its 52-week high at $6.65.
- [By anandjha89]
Company like Alexza Pharmaceuticals (ALXA). It has developed an aerosol delivery system for already-approved drugs, called the Staccato system. The company�� first product, ADASUVE was approved in January 2013. It combines a 1974-vintage anti-psychotic drug, loxapine, with the company�� new delivery device.
Top Performing Companies To Own For 2014: Standard Pacific Corp(SPF)
Standard Pacific Corp. operates as a diversified builder of single-family attached and detached homes in the United States. It constructs homes targeting various homebuyers primarily move-up buyers in metropolitan markets in California, Florida, the Carolinas, Texas, Arizona, Colorado, and Nevada. The company also provides mortgage financing services to its homebuyers; and title examination services to its Texas homebuyers. As of December 31, 2011, it owned or controlled 26,444 homesites and had 166 active selling communities. Standard Pacific Corp. was founded in 1965 and is headquartered in Irvine, California.
Advisors' Opinion:- [By Erika Janowicz]
Compass Point analyst Wilkes Graham updated his housing forecast:
Graham increased assumed ROI's to 9% on average from 7%. Reduced targeted sector price/ book from $190% to 170%. Expects 20-30% growth in starts and new home sales in 2012 and 2013 to stabilize in 2014 and on at approximately 10%. For covered builders, the analyst lowered estimates by 8% and lowered price targets by 10%. Compass Point expects 10% annual growth in single family starts and new home sales and 2-5% pricing growth. Downgraded DR Horton Inc. (NYSE: DHI) from Buy to Neutral and KB Home (NYSE: KBH) from Neutral to Sell. DR Horton's and KB Home's PT was lowered from $23.50 to $20.00 and from $17.50 to $14.00, respectively. Graham reiterated a Buy rating on Ryland Group Inc. (NYSE: RYL) and Standard Pacific Corp. (NYSE: SPF). The analyst raised the PT on Ryland from $50.00 to $50.50 and lowered the PT on Standard Pacific from $10.00 to $9.50. Compass Point reiterated a Neutral rating on Beazer Homes USA Inc. (NYSE: BZH), Hovnanian Enterprises Inc. (NYSE: HOV), Lennar Corp. (NYSE: LEN), PulteGroup, Inc. (NYSE: PHM), and Toll Brothers Inc. (NYSE: TOL). The price target for Beazer and Hovnanian was raised from $15.50 to $24.00 and $5.00 to $5.75, respectively. Graham lowered the PT for Lennar, Pulte, and Toll to $34.50, $17.00, and $31.00.This Week's Data
- [By Sally Jones]
Standard Pacific Corp. (SPF): Reduced
Up 19% over 12 months, Standard Pacific Corp., a residential construction company, has a market cap of $2.27 billion. The current share price is around $8.18. Shares trade at a P/E of 5.70. The company does not pay a dividend.
- [By Louis Navellier]
If we look at those stocks trading with single-digit P/E ratios right now, it becomes a very simple task to separate the wheat from the chaff. There are many well-known stocks trading at low P/E ratios that get horrible grades from our system and should be avoided:
Ryland Homes (RYL) is a name you might hear discussed as a bargain, but the stock to a Sell back in November to a ����and is best avoided. Standard Pacific (SPF) is another builder you should probably avoid as In spite of the low P/E ratio ,you probably want to avoid discount retailer Big Lots (BIG), as a Strong Sell this week.But fear not — there are some great companies with solid fundamentals that earn a Buy ranking from Portfolio Grader and are better candidates for a low-P/E portfolio.
Top Performing Companies To Own For 2014: BJ's Restaurants Inc.(BJRI)
BJ?s Restaurants, Inc. owns and operates casual dining restaurants in the Unites States. The company operates restaurants under the BJ?s Restaurant & Brewery, BJ?s Restaurant & Brewhouse, BJ?s Pizza & Grill, or BJ?s Grill names, which offer deep-dish pizzas, handcrafted beers, appetizers, entrees, pastas, sandwiches, specialty salads, desserts, non-alcoholic beverages, wine, other craft beers, and spirits. As of February 27, 2012, it owned and operated 116 restaurants comprising 10 BJ?s Restaurant & Brewery restaurants, 98 BJ?s Restaurant & Brewhouse restaurants, 7 BJ?s Pizza & Grill restaurants, and 1 BJ?s Grill. The company operates restaurants in California, Texas, Arizona, Colorado, Oregon, Nevada, Florida, Ohio, Oklahoma, Kentucky, Indiana, Louisiana, and Washington. BJ?s Restaurants, Inc. was founded in 1991 and is based in Huntington Beach, California.
Advisors' Opinion:- [By Meetu Anand]
Brinker International (NYSE: EAT ) has been no exception to the trend of falling comps, while BJ's Restaurants (NASDAQ: BJRI ) and Darden Restaurants (NYSE: DRI ) have also followed along�.
Top Performing Companies To Own For 2014: Lincoln Educational Services Corporation(LINC)
Lincoln Educational Services Corporation provides post-secondary education services in the United States. The company offers degree and diploma programs for recent high school graduates and working adults in the areas of studies, such as health science, automotive technology, skilled trades, business and information technology, and hospitality services. As of December 31, 2011, it had 19,204 enrolled students. The company operates 46 schools in 17 states under Lincoln Technical Institute, Lincoln College of Technology, Lincoln College of New England, Nashville Auto-Diesel College, and Euphoria Institute of Beauty Arts and Sciences brand names, as well as offers online programs. Lincoln Educational Services Corporation was founded in 1946 and is headquartered in West Orange, New Jersey.
Advisors' Opinion:- [By Jon C. Ogg]
Teradyne will replace Scholastic Corp. (NASDAQ: SCHL) in the S&P MidCap 400, and Scholastic will replace Lincoln Education Services Corp. (NASDAQ: LINC) in the S&P SmallCap 600. Lincoln Education Services currently ranks 600th in the S&P SmallCap 600 and is no longer representative of the small cap market space.
Top Performing Companies To Own For 2014: Stratasys Inc.(SSYS)
Stratasys, Inc., together with its subsidiaries, engages in the development, manufacture, marketing, and servicing of three-dimensional (3D) printers, rapid prototyping (RP) systems, and related consumable materials for office-based RP and direct digital manufacturing (DDM) markets. The company offers its products as integrated systems consisting of an RP machine and the software to convert the CAD designs into a machine compatible format, and modeling and support materials. Its products enable engineers and designers to create physical models, tooling, jigs, fixtures, prototypes, and end use parts out of production grade thermoplastic directly from a CAD workstation. The company also offers rapid prototyping and production part manufacturing services; and maintenance, leasing/renting, training, and contract engineering services for 3D production systems and 3D printers. Its products are used by design and manufacturing organizations in aerospace, architecture, automotive, business machines, consumer products, defense, direct digital manufacturing of custom parts, educational institutions, electronics, fixtures, jewelry, heavy equipment, medical systems, tooling, medical analysis, mold making, and dental markets. The company markets its products through a network of value-added resellers and distributors in the Americas, Europe, the Middle East, Korea, Taiwan, Japan, and China. Stratasys, Inc. was founded in 1989 and is headquartered in Eden Prairie, Minnesota.
Advisors' Opinion:- [By Steve Heller]
In order to get some perspective on what some of the biggest opportunities are today for 3-D printing companies, I turned to Rich Stump, principal of FATHOM, a highly experienced Stratasys (NASDAQ: SSYS ) reseller and 3-D printing service center. The way Stump sees it, a major driver of future 3-D printing growth will be downstream and one-off applications. In other words, finished products and customized solutions will likely fuel 3-D printing growth in the years ahead. This line of thinking aligns with Wohlers Associates, which believes the 3-D printing industry will grow by 19.3% a year through 2021 to become a $10.8 billion industry.
- [By James E. Brumley]
They say the great ones withstand the test of time. If that's true of stocks (and it is), then it's becoming increasingly safer to say Makism 3D Corp. (OTCMKTS:MDDD) is one of the great ones within the 3D printing world. No, it's neither as big nor as prolific as 3D printer names like 3D Systems Corporation (NYSE:DDD) or Stratasys, Ltd. (NASDAQ:SSYS). Then again, everything is relative; MDDD may well be packing more of a punch for its investors than SSYS or DDD have in a long time.
- [By ICRAOnline]
3-D printing giant Stratasys (SSYS) reported stellar second-quarter 2014 numbers that pushed the stock to close at 14.94% higher and even continued in the after-hour trading, lifting the stock by another 0.8%. The company also provided a solid third quarter outlook, making them even happier. Let�� dig in to find out what happened during the perio, and what are the factors that would help the company to beat expectations in the coming quarters.
No comments:
Post a Comment